Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1924)	3/5/1999 11:19:00 AM
From: Don Miller	Read Replies (1) of 10280

Thanks for the informative response. One thing that I think we stock holders should be aware of is other solutions for the allergic or asthma patients. There is a potential new drug series in trial for since about September. There was a piece on one of the new programs (NBC Nightline, I think)about the general concept. These new drugs are referred to as IG-E Blockers. The IG-E blocker is injected monthly and blocks the receptor site. The great thing about them as I understand is they block all allergins, not just those accessible to desensitizing shoots. Turns out the private company, Tanox, was described as in partnership with Genentech and Amgen on this particular drug. There may also be others working on the same general concept. I deferred investing thinking those two big partners would diminish the reward too much. They should have already been reporting success. I could not turn anything up on IGE blockers, during November and December searches, not even Tanox appeared. Tanox has a web site.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next